The U.S. Securities and Exchange Commission (SEC) has approved a significant change to NYSE American's continued listing standards, introducing a new $5 million minimum market capitalization requirement that could accelerate the delisting of smaller public companies.
Under the SEC's approval order (Release No. 34-106893), NYSE American must immediately suspend trading and commence delisting proceedings when a company's common stock falls below an average market capitalization of $5 million (USD) over 30 consecutive trading days. Unlike many other continued listing deficiencies, companies will not receive a traditional compliance or cure period.
For Canadian companies accessing U.S. capital markets, particularly smaller mining, life sciences, technology, and emerging growth companies, the new rule reinforces an important consideration: maintaining a U.S. exchange listing now requires the same strategic attention as obtaining one.
What Is NYSE American's New $5 Million Continued Listing Requirement?
The SEC approved amendments to Sections 1003 and 1009 of the NYSE American Company Guide establishing a new minimum market capitalization standard.
Under the amended rules:
-
$5 million minimum: A company’s common stock must maintain an average market capitalization of at least $5 million (USD) over a consecutive 30-trading-day period.
-
Immediate suspension and delisting proceedings: Falling below that threshold triggers immediate trading suspension and commencement of delisting proceedings.
-
No automatic cure period: Companies are not entitled to the compliance procedures ordinarily available for certain other continued listing deficiencies.
-
Appeal rights remain: Companies retain the ability to appeal a delisting determination under Part 12 of the NYSE American Company Guide, although an appeal does not guarantee continued trading.
The new requirement became effective upon SEC approval, leaving companies with little room to defer compliance planning. Importantly, the standard measures average market capitalization over 30 trading days, rather than simply testing whether a company's valuation falls below $5 million on a particular day. Companies should understand how this calculation applies to their capital structure and monitor their position before approaching the threshold.
How Does NYSE American's New Rule Compare With Nasdaq's $5 Million Requirement?
The new requirement follows a similar development at Nasdaq, which proposed a $5 million minimum Market Value of Listed Securities (MVLS) standard earlier this year, as discussed in our previous alert, “Nasdaq's New $5 Million Market Value Rule: What Nasdaq Issuers Need to Know to Avoid Immediate Delisting.” SEC staff approved Nasdaq's rule on July 22, 2026, but that approval was stayed, and on September 11, 2026, the SEC granted petitions for review of it.
While both rules target companies with sustained market values below $5 million, their calculation methodologies and review procedures differ. For Canadian companies evaluating U.S. listing options, these developments reinforce the importance of assessing not only initial listing eligibility but also the ability to maintain compliance over time.
What Are the Key Risks for Canadian Companies Listed on NYSE American?
For Canadian companies, particularly those operating in capital-intensive or development-stage industries, market capitalization may fluctuate due to commodity prices, financing cycles, clinical or regulatory milestones, broader market conditions, and investor sentiment.
These fluctuations do not necessarily indicate deterioration in a company’s underlying business. Nevertheless, the new rule establishes an objective threshold that may trigger delisting consequences regardless of the reasons for a sustained decline.
The implications extend beyond exchange compliance. A trading suspension or delisting may affect liquidity, investor participation, access to future financing, and the ability to execute strategic transactions.
The SEC acknowledged concerns that the rule could adversely affect smaller companies that might otherwise recover. However, it concluded that the heightened risks associated with sustained low market capitalization justified the stricter standard.
What Should NYSE American-Listed Companies Do Now?
The absence of a conventional cure period makes early intervention particularly important. Boards, management teams, and advisers should consider the following measures:
-
Monitor market capitalization before compliance becomes an issue. Establish procedures to track the applicable 30-trading-day average, rather than relying solely on daily share prices or existing exchange deficiency notices.
-
Review financing and capital markets strategies. Companies approaching the threshold should assess whether planned financings, strategic transactions, or other legitimate corporate initiatives could support their longer-term market position. Transaction timing and execution risk should be evaluated well before a potential deficiency.
-
Understand the limits of corrective measures. A reverse stock split may increase the trading price per share, but it does not, by itself, increase a company's overall market capitalization. Strategies intended to address minimum bid price deficiencies may therefore be insufficient under the new rule.
-
Prepare for potential delisting consequences. Companies should evaluate applicable appeal procedures, financing arrangements, investor communications, and alternative trading or listing options before a suspension becomes imminent.
What Does the New Rule Mean for Canadian Companies?
The SEC's approval reflects a broader tightening of U.S. exchange listing standards, placing greater emphasis on market capitalization, liquidity, and investor protection. For Canadian companies considering or maintaining a U.S. listing, compliance planning must extend beyond the initial transaction to account for changing market conditions and ongoing capital requirements.
With no conventional cure period available under the new NYSE American rule, early assessment of market capitalization, financing options, and potential delisting exposure is increasingly important.
The interesting question is whether there will be a stay of this new NYSE American rule, like the current stay of the Nasdaq rule.
For guidance on NYSE American listing requirements, U.S. capital markets transactions, and cross-border financing strategies, contact Cozen O'Connor's Canadian Capital Markets & Securities team.